Delivery Order SPE2DB22D9207-SPE2DB24FH4UB

Award Date 11/13/23
Potential Completion Date 12/5/23
Potential Value $32K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-seven thousand eight hundred twenty-nine dollars and seventy-six cents ($37,829.76) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract to supply pharmaceuticals and medical products to the Defense Logistics Agency, with a potential value of up to five million dollars through December 2025. Under this particular delivery...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at forty-three thousand six hundred thirty-nine dollars and twenty cents ($43,639.20) by the Defense Logistics Agency. The delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical products to the Defense Logistics Agency. Under this particular delivery order, DMS Pharmaceutical Group will provide five hundred (500)...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-one thousand five hundred twenty-four dollars and eighty cents ($31,524.80) by the Defense Logistics Agency Troop Support Medical. This order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply various pharmaceutical items and medical products. Under this delivery order, DMS Pharmaceutical Group will provide one thousand (1,000) vial units of...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twelve thousand seven hundred forty-three dollars and sixty-eight cents ($12,743.68) by the Defense Logistics Agency to provide one thousand (1,000) vials of Kcentra. The delivery order was awarded on November 22, 2023 and is to be completed by December 14, 2023. DMS Pharmaceutical Group will supply the pharmaceutical item to the Defense Logistics Agency under an existing indefinite delivery contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 500-unit vials of the pharmaceutical product KCENTRA. The contract has a potential value of $9,430.08 and a completion date of January 25, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to the federal government, particularly the Department of Defense....
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of 1,000 unit vials of the drug KCENTRA. The order, valued at $72,075.36, has an ultimate completion date of June 21, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery orders for a...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a Woman-Owned Small Business, to provide 500 unit vials of the pharmaceutical product KCENTRA. The contract has a completion date of January 30, 2024 and a potential value of $23,575.20. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to...
This is a firm fixed-price delivery order with a potential value of $11,523.20 awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization. The contract is for the delivery of 1,000 unit vials of the pharmaceutical product KCENTRA by October 20, 2022. DMS Pharmaceutical Group Inc. is the prime contractor and there is no set-aside designation for this award. The contract is issued under DMS Pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 500-unit vials of the pharmaceutical product KCENTRA. This order has a potential value of $59,723.84 and a completion date of February 7, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products to military...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $20,465.28, is for the delivery of 1,000 unit vials of the pharmaceutical product KCENTRA. The delivery order has an ultimate completion date of July 7, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy...
  • SPE2DB22D9207
    Indefinite Delivery Contract
  • SPE2DB22D9207-SPE2DB24FH4UB
    Delivery Order

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-one thousand eight hundred ninety-five dollars and sixty-eight cents ($31,895.68) by the Defense Logistics Agency. The delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical products to the Defense Logistics Agency. Under this particular award, DMS Pharmaceutical Group will provide one thousand (1,000) vial units of KCENTRA to the Defense Logistics Agency by December 5, 2023. KCENTRA is a pharmaceutical product used to treat patients, and this delivery order will support medical treatment facilities operated by the Defense Logistics Agency. No set-aside designation was applied to this award.

Generated 2/12/24, 9:43 AM